Live Validation of the Lower Eyelid Steatoblepharon Severity (LESS) Scale

Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis

NCT01028027 ·Status: COMPLETED ·Phase: PHASE3

Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)

NCT02607683 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome

NCT06831253 ·Status: RECRUITING ·Phase: NA

ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects

NCT05066698 ·Status: TERMINATED ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants

NCT05992922 ·Status: TERMINATED ·Phase: PHASE2

Changes of Tear-film Lipid Layer Thickness and Ocular Aberration After Treatment of Meibomian Gland Dysfunction

NCT02618304 ·Status: COMPLETED ·Phase: NA

Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers

NCT02102464 ·Status: COMPLETED ·Phase: NA

Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis

NCT02952079 ·Status: COMPLETED ·Phase: NA

Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery

NCT01808560 ·Status: COMPLETED ·Phase: NA

A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)

NCT00851734 ·Status: COMPLETED ·Phase: PHASE1

The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease

NCT04792580 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Clinical Feature and Treatment of Microsporidial Keratoconjunctivitis

NCT03555409 ·Status: UNKNOWN

Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax

NCT04555694 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease

NCT07111013 ·Status: WITHDRAWN ·Phase: PHASE3

Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction

NCT03055832 ·Status: COMPLETED ·Phase: NA

Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease

NCT03414645 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers

NCT05505292 ·Status: COMPLETED ·Phase: PHASE4

Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye

NCT00560638 ·Status: COMPLETED ·Phase: PHASE2

LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease

NCT02365519 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome

NCT02147509 ·Status: COMPLETED ·Phase: NA

An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake

NCT04280653 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)

NCT05683496 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests

NCT04125134 ·Status: TERMINATED ·Phase: PHASE4

Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator

NCT02526290 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation

NCT06217796 ·Status: COMPLETED ·Phase: PHASE4